Complementary data such as sleep studies, pulmonary function tests, and biomarkers including BNP were also unavailable, limiting our ability to identify conditions such as OSA, COPD, or HFpEF more precisely. This evidence concerns the gene NPPB and chronic obstructive pulmonary disease.